These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11849125

  • 1. Review article: rabeprazole-based therapy in Helicobacter pylori eradication.
    Barth J, Hahne W.
    Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():31-3. PubMed ID: 11849125
    [Abstract] [Full Text] [Related]

  • 2. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
    Inaba T, Mizuno M, Kawai K, Yokota K, Oguma K, Miyoshi M, Take S, Okada H, Tsuji T.
    J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
    Hawkey CJ, Atherton JC, Treichel HC, Thjodleifsson B, Ravic M.
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
    [Abstract] [Full Text] [Related]

  • 4. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
    Miki I, Aoyama N, Sakai T, Shirasaka D, Wambura CM, Maekawa S, Kuroda K, Tamura T, Kita T, Sakaeda T, Okumura K, Kasuga M.
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
    [Abstract] [Full Text] [Related]

  • 5. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
    Kawabata H, Habu Y, Tomioka H, Kutsumi H, Kobayashi M, Oyasu K, Hayakumo T, Mizuno S, Kiyota K, Nakajima M, Kimoto K, Inokuchi H, Kawai K.
    Aliment Pharmacol Ther; 2003 Jan; 17(2):259-64. PubMed ID: 12534411
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ, Park DI, Oh SJ, Song MJ, Choi WH, Hong CH, Park JH, Kim HJ, Cho YK, Shon CI, Jeon WK, Kim BI.
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [Abstract] [Full Text] [Related]

  • 7. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
    Furuta T, Shirai N, Xiao F, Takashita M, Sugimoto M, Kajimura M, Ohashi K, Ishizaki T.
    Hepatogastroenterology; 2003 Aug; 50(54):2274-8. PubMed ID: 14696516
    [Abstract] [Full Text] [Related]

  • 8. Triple therapy as a cure for Helicobacter pylori infection.
    Bardhan KD.
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S27-30. PubMed ID: 8930577
    [Abstract] [Full Text] [Related]

  • 9. Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.
    Furuta T, Shirai N, Sugimoto M, Ohashi K, Ishizaki T.
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1175-6. PubMed ID: 14653841
    [No Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA, Knifton A, Thirlwell D, Cockayne A, Jenkins D, Hawkey CJ, Atherton JC.
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [Abstract] [Full Text] [Related]

  • 11. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Vallve M, Vergara M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1149-56. PubMed ID: 12030958
    [Abstract] [Full Text] [Related]

  • 12. Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
    Wong BC, Wong WM, Yee YK, Hung WK, Yip AW, Szeto ML, Li KF, Lau P, Fung FM, Tong TS, Lai KC, Hu WH, Yuen MF, Hui CK, Lam SK.
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1959-65. PubMed ID: 11736727
    [Abstract] [Full Text] [Related]

  • 13. Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review.
    Ulmer HJ, Beckerling A, Gatz G.
    Helicobacter; 2003 Apr; 8(2):95-104. PubMed ID: 12662376
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS, Berardi RR.
    J Am Pharm Assoc (Wash); 2000 Apr; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [Abstract] [Full Text] [Related]

  • 15. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
    Louw JA, van Rensburg CJ, Hanslo D, Grundlings HD, Girdwood AH, Marks IN.
    Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N.
    Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
    [Abstract] [Full Text] [Related]

  • 17. Review article: the pharmacology of rabeprazole.
    Williams MP, Pounder RE.
    Aliment Pharmacol Ther; 1999 Aug; 13 Suppl 3():3-10. PubMed ID: 10491723
    [Abstract] [Full Text] [Related]

  • 18. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R.
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V, Boeck W, Richter C, Marre R, Adler G, Glasbrenner B.
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [Abstract] [Full Text] [Related]

  • 20. The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy.
    Eisig JN, André SB, Silva FM, Hashimoto C, Moraes-Filho JP, Laudanna AA.
    Arq Gastroenterol; 2003 Aug; 40(1):55-60. PubMed ID: 14534667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.